LL-37 disrupts microbial membranes through electrostatic interaction with negatively charged phospholipids. It also activates FPRL1 receptors on immune cells, promoting chemotaxis and cytokine release. Additionally, LL-37 inhibits biofilm formation and stimulates angiogenesis and re-epithelialization in wound healing models.
LL-37 — Human Cathelicidin Antimicrobial Peptide
A 37-amino acid antimicrobial peptide and the only human cathelicidin, studied for broad-spectrum antimicrobial activity, immune modulation, and wound healing.
CAS 154947-66-7 • 4,493 g/mol • Prepared for research use • Per research workflow
LL-37 Structure
Reference identifiers are batch-specific for coded materials and are documented on the lot COA/SDS rather than inferred or estimated.
Mechanism of Action
LL-37 Overview
LL-37 is a 37-amino acid peptide and the sole cathelicidin-derived antimicrobial peptide found in humans. It is produced by cleavage of the precursor protein hCAP-18 (human cationic antimicrobial protein 18) and is expressed in neutrophils, macrophages, epithelial cells, and other immune cell types. In preclinical research, LL-37 has demonstrated broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, fungi, and enveloped viruses. Its mechanism involves direct membrane disruption of microbial cells as well as immunomodulatory signaling through formyl peptide receptor-like 1 (FPRL1) and other pattern recognition pathways. Beyond its antimicrobial properties, LL-37 has been studied for its role in wound healing, anti-biofilm activity, and modulation of innate and adaptive immune responses. Research interest has expanded into chronic infections, inflammatory conditions, and tissue repair applications. For research use only. Not intended for human consumption.
Purity & Testing
LL-37 is listed as 10mg lyophilized vial. Catalog identity: CAS 154947-66-7; formula C205H340N60O53; molecular weight 4,493 g/mol. The lot COA for LL-37 is available in your account. Finnrick Analytical performs HPLC purity analysis and mass spectrometry identity confirmation on that lot.
- Catalog configurations: 10mg lyophilized vial
- CAS: 154947-66-7
- Formula: C205H340N60O53
- Molecular weight: 4,493 g/mol
See the LL-37 COA page.
Storage & Handling
Store the lyophilized powder at -20°C, protected from light; bring to room temperature before opening. For in-vitro preparation use an appropriate laboratory diluent.
Shipping
Ships worldwide from 6 distribution centers via USPS Ground Advantage
Available for direct research purchase
Research-use-only products are sold strictly for laboratory and research purposes. By purchasing, you acknowledge that these products are not intended for human or veterinary use, and you agree to PharmaOrder's RUO terms of service.
Published Research
Selected peer-reviewed studies referenced in this product overview.
FAQ
What is LL-37 and why is it significant?
How does LL-37 differ from other antimicrobial peptides?
How should LL-37 be stored?
Is LL-37 available for direct purchase?
Compare LL-37
Related Products
BPC-157
A pentadecapeptide derived from human gastric juice, studied for its effects on tissue healing and cytoprotection in research settings.
TB-500
A synthetic fragment of thymosin beta-4 studied for its role in actin regulation, cell migration, and tissue-repair pathways in research models.
KPV
A tripeptide (Lys-Pro-Val) derived from alpha-MSH studied for its potent anti-inflammatory properties through NF-κB signaling inhibition.
Ready to order LL-37?
In stock. Ships within 24 hours, with tracking.
Order Now